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RESUMO.- [Os componentes do sangue afetam a pro-
dução de (ERO) pelas células sinoviais de equinos in 
vitro?] Produtos derivados do sangue são comumente usa-
dos, tanto no homem como em cavalos, para tratar diver-
sas doenças musculoesqueléticas, principalmente devido 
a seus efeitos antioxidantes e anti-inlamatórios. Contudo, 
efeitos antioxidantes nunca foram demonstrados em cé-
lulas de líquido sinovial in vitro. Caso esses efeitos sejam 
efetivamente demonstrados, uma nova perspectiva para 
justiicar a aplicação clínica desses produtos poderia surgir. 
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Blood-derived products are commonly administered to horses and humans to treat 
many musculoskeletal diseases, due to their potential antioxidant and anti-inlammatory 
effects. Nevertheless, antioxidant effects have never been shown upon horse synovial luid 
cells in vitro. If proved, this could give a new perspective to justify the clinical application 
of blood-derived products. The aim of the present study was to investigate the antioxidant 
effects of two blood-derived products – plasma (unconditioned blood product - UBP) and 
a commercial blood preparation (conditioned blood product - CBP)4 – upon stimulated 
equine synovial luid cells. Healthy tarsocrural joints (60) were tapped to obtain synovial 
luid cells; these cells were pooled, processed, stimulated with lipopolysaccharide (LPS) or 
phorbol 12-myristate 13-acetate (PMA), and evaluated by low cytometry for the produc-
tion of reactive oxygen species (ROS). Upon addition of any blood-derived product here 
used – UBP and CBP – there was a signiicant decrease in the oxidative burst of synovial 
luid cells (P<0.05). There was no difference between UBP and CBP effects. In conclusion, 
treatment of stimulated equine synovial cells with either UBP or CBP eficiently restored 
their redox equilibrium.
INDEX TERMS: Horse, synovial luid, plasma, antioxidant, osteoarthritis.
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Sendo assim, o objetivo do presente estudo foi investigar os 
efeitos antioxidantes de dois produtos derivados de sangue 
– plasma (produto de sangue não condicionado - UBP) e 
uma preparação comercial de sangue (produto de sangue 
condicionado - CBP)4 – sobre células estimuladas extraídas 
do líquido sinovial de equinos. Articulações tibiotársicas 
saudáveis (60) foram puncionadas para a obtenção de cé-
lulas de líquido sinovial; essas células foram concentradas, 
processadas, estimuladas com lipopolissacarídeos (LPS) 
ou forbol 12-miristato 13-acetato (PMA), e avaliadas por 
citometria de luxo quanto à produção de espécies reativas 
de oxigênio (ROS). Após a adição de ambos os produtos de-
rivados do sangue – UBP ou CBP – ocorreu uma signiicati-
va queda no burst oxidativo em células do líquido sinovial 
(P<0,05). Não houve diferença entre os efeitos de UBP e 
CBP. Em conclusão, tratamento de células estimuladas do 
líquido sinovial de equinos com UBP ou CBP restaurou ei-
cientemente o equilíbrio redox das células.
TERMOS DE INDEXAÇÃO: Equino, líquido sinovial, plasma, antio-
xidante, osteoartrite.
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INTRODUCTION
Osteoarthritis (OA) is characterized by degeneration and 
loss of articular cartilage and development of new bone on 
joint surfaces and margins.  Reactive oxygen species (ROS) 
are among the agents implicated in the degradation of car-
tilage matrix (Henrotin et al. 2003, Petrov et al. 2005) and 
reduction of synovial luid viscosity (Greenwald & Moy, 
1980). ROS has been proved to be deleterious to several 
constituents of the musculoskeletal system (Greenvald & 
Moy 1980, Henrotin et al. 2003, Ostalowska et al. 2006). 
Generation of superoxide and other ROS has been demons-
trated in response to inlammatory cytokines and injurious 
mechanical forces in both equine and human cartilage (Di-
mock et al. 2000, Regan et al. 2005).
Plasma has been shown to contain several antioxidant 
systems that counteract the generation of ROS (Sarban et 
al. 2005, Adib-Conquy & Cavaillon 2009). It is also a source 
of growth factors, with potential therapeutic applications 
(Smith et al. 2006). Recently, autologous blood-derived 
products such as cell-free autologous conditioned serum 
(ACS), platelet rich plasma (PRP) and acellular bone mar-
row aspirate (ABM) have gained special attention for their 
anti-inlammatory and/or healing enhancing properties. 
However, their antioxidant effects have not yet been stu-
died but, if demonstrated, could add a new perspective to 
justify its clinical application.
The objective of the present study was to verify by low 
cytometry technique the effects of two blood-derived pro-
ducts on the generation of ROS by synovial luid cells.
MATERIALS AND METHODS
Animals
Thirty eight Standarbred horses, three to ten years of age, fed 
the same diet, clinically sound (free from lameness and/or joint 
effusion, with negative lexion tests) and without radiological sign 
of OA were used.  Synovial luid samples were aseptically collec-
ted from 30 horses, left and right tarsocrural joints (60 joints), via 
a standard dorsomedial approach according to Moyer (2007), to 
constitute the synovial luid cell pool.
The remaining horses (8) were used for blood collection, each 
horse providing two blood samples (60 mL) to be differently pro-
cessed, giving origin to two distinct blood-derived products.
Experiments were performed in agreement with the Ethical 
Principles in Animal Research adopted by Bioethical Commission 
of the School of Veterinary Medicine and Animal Science of the 
University of São Paulo (Proc. 1142/2007).
Synovial luid cell pool preparation
Immediately after tapping, the synovial luid sample was 
transferred to a sterile tube containing EDTA, and kept on ice for 
no longer than 2 hours, until processing at Laboratório de Far-
macologia e Toxicologia do Departamento de Patologia Animal da 
FMVZ-USP. As normal equine synovial luid presents low cellula-
rity, which would constrain the analysis, all samples of synovial 
luid were pooled to give enough amounts of synovial luid cells 
for low cytometry analysis. The cells were obtained from syno-
vial luid pool by centrifugation at 300xg, 15 minutes, 4°C. The 
cell pellets were washed and resuspended in 2mL of phosphate-
-buffered (PBS). Cellular viability was estimated by Trypan Blue 
assay. The cells were counted in a Neubauer chamber, and the 
concentration was adjusted to 1x105 cells/100µL in PBS.
Preparation of blood-derived products
From eight horses, two blood samples were collected accor-
ding to routine aseptic technique from each horse (16 samples). 
One sample was drawn in a special 60mL syringe, provided by a 
commercial kit4 illed with pre-treated medical beads, as provi-
ded by the manufacturer; the other was drawn in regular 60mL 
polypropylene syringes illed with heparin. Both were handled in 
the same manner: blood was incubated in the syringes at 37°C for 
24 hours with 5% CO
2,
 in a horizontal position, and centrifuged at 
600xg for 10 minutes to yield a plasma-like product.
The inal product obtained with the syringe provided in the 
commercial kit will be referred to as conditioned blood product 
(CBP) and the one obtained through regular syringes as uncon-
ditioned blood product (UBP).  After iltration through a 0.22μm 
micro ilter, 2mL aliquots were stored at -20°C until used. At the 
moment of use, each aliquot was diluted 1:5 in PBS.
Measurement of oxidative burst
The following reagents were used to stimulate oxidative 
burst: (1) phorbol 12-myristate 13- acetate (PMA) (Sigma, St 
Louis, MO), 1mg/mL in ethanol, stored at -20°C. It was used to 
prepare, at the moment of use, a 100ng/mL solution in PBS; (2) 
lypopoolysaccharide (LPS)(strand 055:B55, Sigma, St Louis, MO ), 
1mg/mL in PBS, stored at -20°C. It was used to prepare, at the mo-
ment of use, a 10μg/mL solution in PBS. The luorescent dye used 
was dichloroluorescein diacetate (DCFH-DA, Molecular Probes) 
at a inal concentration of 0.3mM. DCFH-DA diffuses into the cells 
and is hydrolyzed to the non-luorescent 2’7’-dichloroluorescein 
(DCFH) during the polymorphonuclear cells oxidative burst. In-
tracellular DCFH is oxidized to highly luorescent dichloroluores-
cein (DCF) by peroxidase and H
2
0
2
. DCF then emits a luorescent 
signal that is measured by low cytometer.
Generation of reactive oxygen species (ROS) and low cyto-
metry
The oxidative burst assays for equine synovial luid cells were 
performed according to Massoco et al. (2006). Control sample 
(negative controls) contained 1x105 synovial cells (in 100μL sus-
pension), 200μL of DCFH-DA and 700μL of sterile PBS (without 
stimulants), in 1mL inal volume. These samples were incubated 
in water bath at 37°C for 20 minutes, giving the basal levels of ROS 
production. To evaluate the stimulated oxidative burst, identical 
incubation mixtures were prepared, containing the same number 
of cells, and the incubation with DCFH-DA was followed by incu-
bation with 100 μL of either PMA or LPS. To analyze the effects of 
two blood-derived products, 200μL of CPB or UPB were added to 
cells loaded with DCFH, and with or without stimulants, followed 
by PBS volume to reach a 1mL inal volume and incubating under 
the same conditions. Other dilutions of CPB and UPB were used 
on pilot experiments (data not shown) and the lowest dilution 
which had anti-oxidant effects were used (1:5).
The cells were collected by centrifugation (300xg, 10 minu-
tes, 4°C), and the supernatant was discarded. Contaminating 
erythrocytes were removed by hypotonic lysis with 2mL of 0.2% 
NaCl for 20 seconds, followed by washing with 2mL of 1,6% NaCl 
to restore isotonicity. Samples were again centrifuged (300xg, 10 
minutes, 4°C), and inally the cells were resuspended in 300μL of 
PBS and analyzed by low cytometry (FacsCALIBUR, Benton Di-
ckinson Immunocytometry Systems). Samples were evaluated in 
triplicates.
Cells were gated on the basis of their characteristic mor-
phology, i.e. characteristic of granularity (side scatter) and size 
(forward scatter) of leukocytes and acquired in a low cytometer 
using the Cell Quest Pro software (Becton Dickinson). Green mean 
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luorescence was recorded as oxidative burst. Data from 10.000 
events were collected excluding the lymphocyte population. Mean 
intensity of luorescence after oxidation was evaluated. Samples 
were evaluated in triplicates.
Barlett’s test showed that data concerning oxidative burst 
were parametric, and thus, one-way Analysis of Variance compa-
rison of means of cellular luorescence was employed. The Instat 
Statistic Analysis Package was used and the level of signiicance 
set at P<0.05.
RESULTS
Oxidative burst response in synovial cells
Flow citometry data on igure 1A showed leukocytes 
and synovial cells identiied by typical side scatter (SSC) 
versus forward scatter (FSC) cytogram of equine synovial 
luid. This igure is representative of equine synovial cellu-
lar pool and revealed mononuclear (MNC) (synoviocytes, 
monocytes and macrophages) and polymorphonuclear cell 
population (PMN) (neutrophil) that was gated according 
to their granularity and size (R1) thus excluding debris 
cellular of analysis. Based on this cytogram we could set 
histograms where the more green luorescence a cell emits 
(corresponding to more ROS), the farther to the right the 
cell data will appear on the histogram. Figure 1B-G shows 
a measurement of green mean luorescence witch is repre-
sentative of oxidative burst of DCFH-loaded MNC and PMN 
cells after incubation with stimulants and blood-derived 
products preparation.
Even though PMA stimulated synovial luid cells with 
greater magnitude, both stimulants PMA and LPS were efi-
cient in inciting oxidative burst. The mean intensity of lu-
orescence emission was signiicantly increased (P=0.03) in 
synovial luid cells after the addition of PMA (325.11±0.1) 
or LPS (131.43±0.1) when compared with basal level 
(93.49±01) (Fig.2).
Both blood-derived products –UBP and CBP– signii-
cantly decreased the mean intensity of ROS production, 
causing equivalent decreases in the intensity of the respi-
ratory burst, irrespectively of the stimulating agent (PMA 
or LPS). UBP decreased the mean luorescence induced 
by PMA to 47.37±4.8, and by LPS to 30.72±2.39 (P<0.05). 
CBP decreased the mean luorescence stimulated by PMA 
to 45.92±10.19, and by LPS stimulation to 58.28±12.37 
(P<0.05) (Fig.2)
DISCUSSION
Several studies have been performed on the mechanisms 
through which blood-derived products can achieve the-
Fig1. Analysis of the oxidative burst 
based on forward and side scat-
ter cytograms (FSC/SSC) (A) 
and luorescence channel his-
tograms (X-axis is the amount 
of green luorescence), corres-
ponding to DCFH luorochrome 
of representative in vitro incu-
bation: LPS (B); PMA (C); LPS 
plus CBP (D); LSP plus UBP (E); 
PMA plus CBP (F); PMA plus 
UBP (G).
Fig.2. Comparison of the effects of CBP and UBP samples on mean 
luorescence intensity of equine synovial luid cells incubated 
without (basal) or with LPS and PMA. Results are expressed as 
geometric mean ± SD. 
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rapeutic effects on orthopedic lesions. However, the up to 
now identiied mechanisms seem to come in play at a later 
stage of the inlammatory or healing process (Schnabel et 
al. 2008, Sutter 2007), and studies on their effects on redox 
imbalances have not yet been done.
In the present study, we have shown that synovial luid 
cells stimulated with either PMA or LPS presented in inten-
se production of ROS, mimicking the response to an acute 
injury. The fast response points towards the involvement of 
constitutive, intrinsic mechanisms or agents (Bours et al. 
2006).
Both blood-derived preparations, CBP and UBP, have 
shown antioxidant properties, probably through restora-
tion of redox balance after the PMA and LPS challenge.
Our results also show that the commercial device (glass 
beads) used to prepare CBP was not necessary to produce 
the antioxidants response, since UBP (plasma) led to simi-
lar results. The premise that the special syringe designed 
for blood collection may play a role in whole blood stimu-
lation and generation of antioxidant substances was not 
conirmed in our experiment. It is also possible that other 
factors, such as interaction of blood with artiicial surfaces, 
time of incubation, temperature, etc., could also be stimu-
lating factors.
 Corroborating these indings, it was recently shown 
that the levels of anti-inlammatory cytokines – interleu-
kin 1 receptor antagonist (IL-1ra), interleukin 10 (IL-10) 
and tumor growth factor-β (TGF-β) – were the same in 
blood-derived products obtained by incubation of whole 
blood with either specially customized syringes containing 
glass beads or regular glass red-top Vacutainer tubes. Only 
for insulin-like growth factor-1 (IGF-1), the incubation of 
blood in the customized syringes led to signiicantly incre-
ased growth factor production (Hrara et al. 2011).
The contact of blood with artiicial surfaces is known 
to induce an inlammatory response, with activation of 
leukocytes and platelets, as well as complement and other 
plasma cascade systems. In this sense, the stimulatory ac-
tion of medical-grade glass on whole blood during incuba-
tion reported by Meijer et al. (2003) is the principle behind 
the concept of the special syringe. Other materials, such 
as polyvinylchloride (PVC), induce a substantial increase 
in leukotriene B4, prostaglandin E2 and thromboxane B2, 
after incubation of blood for 4 hours and activate comple-
ment system, primarily through the alternative pathway 
(Lappegard et al. 2005).  The effects of PVC-induced IL-1β 
and IL-10 have also been described (Lappegard et al. 2004).
As contact stimulation with glass beads in the commer-
cial device was not responsible for increased anti-inlam-
matory cytokine production other factors must play a part. 
Another variable, length of incubation, has been shown to 
play an important role in cytokine production (Jansky et al. 
2003). Also, the relatively long incubation time of blood-
-derived products used in this experiment (24 hours) was 
shown to be necessary for some of the anti-inlammatory 
cytokines to induce its effects (Gallová et al. 2004) and as 
demonstrated by Bussolati et al. (1997), incubation of mo-
nocytes and polymorphonuclear leukocytes with IL-10 for 
24 hours before stimulation, decreased superoxide produc-
tion as a late effect, in despite of an early increment in ROS 
production observed in the irst hours of incubation (Remi-
ck et al. 2000).
Effects of plasma and serum on the oxidative burst of 
blood polymorphonuclear leukocytes (PMNLs) have been 
already described (Lanser et al. 1986, Zimmerman et al. 
1989, Pascual et al. 1998, Fumeaux et al. 2004). They can 
be contradictory depending on the source of plasma: plas-
ma or serum from septic/trauma patients had a depressant 
effect on the generation of ROS by stimulated PMNLs from 
a healthy donor (Pascual et al. 1998); conversely, plas-
ma from normal patients signiicantly enhanced the pha-
gocytic capacity and ROS generation in PMNLs from septi-
cemic patients (Wenisch & Graninger 1995). These studies 
implicated IL-10 and IL-1ra as the main anti-inlammatory 
mediators, responsible for diminished ROS generation 
(Pascual et al. 1998, Fumeaux et al. 2004, Adib-Conquy & 
Cavaillon, 2009). According to Frisbie et al. (2006) synovial 
luid concentration of IL-1ra was increased following treat-
ment with autologous conditioned serum.
Indeed, culture of whole blood for 24 hours was found 
to signiicantly increase production the anti-inlammatory 
cytokines IL-10 and IL-1ra independent of treatment of 
blood, indicating that up regulation was a consequence of 
incubation time rather than treatment. More than that, the 
increase was of equal statistic signiicance between treat-
ments. When cytokine production was observed with only 
one hour of incubation, IL-1ra and IL-10 levels were signi-
icantly lower (Hraha et al. 2011).
On the nature of the antioxidant blood component(s), 
IL-10 seems to be one of the most attractive alternatives to 
explain the observed reduction in PMN and MNC oxidative 
burst in this experiment. IL-10 has been shown to be rela-
ted to plasma’s depressant effect on ROS production (Bus-
solati et al. 1997, Dang et al. 2006) in a similar fashion to 
our results; its anti-inlammatory effects on human neutro-
phil respiratory burst involves inhibition of proper functio-
ning of the enzyme nicotinamide adenine nucleotide phos-
phate oxidase (NADPH) (Dang et al. 2006).
NADPH is dormant in non-activated cells, and its com-
ponents in the resting state are present in two different 
compartments, the plasma membrane and the cytosol (Vig-
nais 2002). Inhibition of phosphorylation of one of its cyto-
solic subunits, p47PHOX   through a decrease in extracellular 
signal regulated kinase 1/2, is the mechanism responsible 
for the impairment in enzyme function.  Phosphorylation 
of the cytosolic component p47PHOX is one of the key intra-
cellular events associated with NADPH oxidase activation, 
and is essential for the conformational changes that will 
initiate formation of the active oxidase.  Dang et al. (2006) 
were able to demonstrate the inhibitory effect of IL-10 on 
p47 PHOX phosphorylation and ERK 1/2 activity 20 minutes 
after incubation of freshly isolated PMNs with IL-10. The 
intracellular signaling pathways initiating these events 
must thus, occur early (Dang et al. 2006). In the present 
experiment one of the striking observations regarding the 
antioxidant effect of conditioned and unconditioned blood 
products was its rapid onset. Rapid inactivation of NADPH 
oxidase could be due to several processes, including recep-
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tor desensitization, uncoupling of transduction pathways 
and modulation of the phosphorylation of NADPH oxidase 
components, such as p47 PHOX and p67 PHOX, and would ex-
plain rapid inhibition of the oxidative burst.
These properties, together with the extremely favorable 
conditions for its production, turn IL-10 into a suitable can-
didate for the soluble factor present in the blood-derived 
products in this experiment, responsible for the fast down 
regulation of PMN’s respiratory burst.
Another plausible candidate for the plasma soluble fac-
tor responsible for decreasing ROs production would be 
IL-1 ra, as it blocks the action of IL-1α and IL-1β ligands 
by competitive inhibition at the IL-1 receptor level, in vi-
tro and in vivo (Dinarello 1998). IL-1 antagonism through 
occupation of its receptor is capable of reducing ROS pro-
duction, as IL-1’s role in ROS generation have already been 
demonstrated by Davies et al (2008).
IL-1ra is produced by monocytes and macrophages af-
ter LPS stimulation in human volunteers (Dinarello 1998) 
and is also induced by in vitro exposure of whole blood to 
chromium sulphate or borosilicate treated glass beads, as 
in the syringes provided in the commercial kit employed; 
with this processing a 140-fold increase in IL-1ra is obser-
ved after a 24 hour incubation period, due to its de novo 
production (Frisbie et al. 2006).
Although the present study does not yield information 
on the speciic antioxidant component(s) present in the 
blood-derived products used as treatments, it clearly sho-
ws that their production is not related to the physical devi-
ce provided by the commercial kit, but to the steps adopted 
in blood processing. The magnitude of this antioxidant ge-
neration is suficient to signiicantly inhibit ROS generation 
incited by all stimuli employed here. Another particular 
feature of this experiment is that it compares the perfor-
mance of the conditioned and the unconditioned blood 
products regarding their potential as antioxidant therapies, 
clarifying the effects (or lack of) of this “conditioning”.
Whatever the main anti-inlammatory cytokines pre-
sent in CBP and UBP are, the remarkable effect associated 
with their up regulation is the rapid induction of inhibition 
of the respiratory burst of PMNs from equine synovial cells 
luid challenged with classical pro-inlammatory stimu-
lants observed in this experiment.
This effect has not been demonstrated before for blood-
-derived products intended for use in musculoskeletal 
injuries, although free radicals as mediators of joint, ten-
don and ligament dysfunctions and antioxidants, as tools 
to counteract their actions, have been extensively studied 
(Greenwald & Moy, 1980, Bates et al. 1984, Henrotin et al. 
2003, Regan et al. 2005, Loeser 2006, Davies 2008).
Blood-derived products tested here would be a favora-
ble intervention in the genesis of ROS-mediated tissue da-
mage, by being able to neutralize the enzyme responsible 
for it.
CONCLUSION
Plasma (UBP) exhibited an in vitro antioxidant effect on 
cells from synovial luid, as evidenced by its ability to ma-
rkedly reduce the generation of free radicals by synovial 
leukocytes. This effect was statistically equivalent to the 
one exerted by a commercial blood preparation. The re-
sults observed in vitro should encourage clinical trials to 
determine if plasma has antioxidant effects in vivo on cells 
of the synovial luid, and if these effects have clinically ob-
servable effects on suppressing joint inlammation.
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